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ABSTRACT
Cellular senescence can be broadly defined as a stable, yet essentially irreversible, loss of 
proliferative capacity. Historically, senescence is described as a negative outcome of advanced 
cellular age. It is now clear, however, that senescence represents a dynamic autonomous stress 
response, integral to long-term tumour suppression. Intriguingly, transient induction of a 
senescent phenotype has actually been suggested to promote regeneration in both liver and skin. 
Here we explored the role of senescence in pathological aged and diabetic murine wound 
healing. Aged and diabetic wounds possessed greater numbers of senescent cells, while diabetic 
macrophages maintained altered retention of polarisation and produced a CXCR2-enriched 
SASP. Of translational relevance, targeted expression of CXCR2 in primary human dermal 
fibroblasts led to paracrine induction of nuclear p21. Further, a selective agonist to CXCR2 was 
able to reverse delayed healing in diabetic mice and accelerate ex vivo human skin wound 
healing. Collectively these data suggest a hitherto unappreciated role for CXCR2 in mediating 
cellular senescence in pathological wound repair.
Key Words: Senescence, Wound Healing, Ageing, Diabetes, Macrophage Polarisation.
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INTRODUCTION
Cellular senescence, first described by Hayflick and Moorhead (1961), is broadly defined as a 
stable yet essentially irreversible loss of cellular proliferative capacity (Demaria et al, 2014; 
Jun and Lau, 2010). A wealth of evidence supports senescence as an autonomous anti-cancer 
mechanism, evolved to halt incipient neoplastic cellular transformation in young organisms 
(Campisi and Robert, 2014). Intriguingly, senescent cells are also apparent in noncancerous 
situations (e.g. fibrosis) and accumulate during ageing (Campisi and di Fagagna, 2007; Jun and 
Lau, 2010), yet the direct role of senescence in ageing and subsequent disease states remains to 
be fully elucidated. 
Senescent cells show flattened morphology and accumulate with chronological age (Campisi 
and di Fagagna, 2007). Senescence is induced by a number of age-related mechanisms, 
including repeated cell division (reviewed in Tchkonia et al, 2013), telomere shortening and 
increased reactive oxygen species (ROS; Di Micco et al, 2006; Passos et al, 2010). Successive 
activation of anti-tumorigenic networks is controlled at the nexus by the p53 transcriptional 
regulator. p53 directly transactivates the proliferation inhibitor, p21 (He et al, 2007), therefore 
preventing cyclin dependent kinase (CDK) 2-mediated pRb (retinoblastoma protein) 
inactivation (Beauséjour et al, 2003). Similarly, p16 transcription prevents CDK4 and CDK6-
mediated phosphorylation of pRb (Takahashi et al, 2006). As pRb naturally binds to E2F/DP 
transcription factor complexes (Dimova and Dyson, 2005), failure to phosphorylate pRB 
inhibits transcription of E2F target genes (Narita et al, 2003; Malumbres and Barbacid, 2005); 
hence, progression from the G1 to S phases is prevented. Despite species-specific differences, 
both p21 and p16 have strong causal links with human ageing (Berry et al, 2017; Peng et al, 
2015; Kim et al, 2015) and murine experimental models (Baker et al, 2008; Baker et al, 2011; 
Choudhury et al, 2007).
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Although unable to divide, senescent cells remain metabolically active. They do so via a SASP 
(senescence-associated secretory phenotype), demonstrated by an increase in the secretion of 
pro-inflammatory cytokines (e.g. the interleukins IL-1a, IL-6, IL-8), growth factors 
(transforming growth factor, TGF-β) and proteases (matrix metalloproteinases, MMPs) that 
actively alter the tissue microenvironment (Freund et al, 2010). The SASP feature of senescent 
cells is a DNA damage response (DDR), and as a result, heavily contributes to age-related 
functional decline (Rodier et al, 2009). More recently, senescence has been experimentally 
manipulated to discover its causal roles in driving progeroid pathology (Baker et al, 2011; Baker 
et al, 2016).
The SASP is also implicated in the aetiology of many chronic diseases (e.g. atherosclerosis, 
Erusalimsky and Kurz, 2005), by allowing low abundance senescent cells to exert strong, local 
tissue effects. For example, the presence of an obesity-driven pro-inflammatory SASP (Schafer 
et al, 2016) has been suggested to mediate insulin resistance and the development of type II 
diabetes mellitus (T2DM) in both mice (Minamino et al, 2009) and humans (Spranger et al, 
2003). Interestingly, fundamental roles for macrophages (Mφs) in mediating this 
“metainflammation”, or metabolically driven inflammation, have been elucidated. Here, many 
Mφ-specific cytokines form part of the SASP (e.g. MCP-1; Kamei et al, 2006; Prattichizzo et 
al, 2018; Xu et al, 2003), while SASP components are known to act on classical Mφ receptors 
(e.g. CXCR1, CXCR2, CX3CR1, reviewed in Sagiv and Krizhanovsky, 2013).
As described, senescence is a stochastic chronic mechanism related to ageing and pathology, 
but a handful of studies have demonstrated the importance of damage-induced senescence in 
arbitrating wound healing (e.g. Demaria et al, 2014; Jun and Lau, 2010). Wound-induced 
senescence remains transient, as following tissue repair, senescent cells are cleared via 
immunosurveillance (Childs et al, 2014). Mφs also play a crucial role in facilitating tissue repair 
by mediating granulation, angiogenesis and remodelling events (reviewed in Koh and DiPietro, 
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2011). Mφs switch from a pro-inflammatory (M1-like) state to a pro-healing (M2-like) state to 
aid wound resolution. However, in models of delayed healing, such as diabetes, a heightened 
pro-inflammatory Mφ response is observed (Bannon et al, 2013; Khanna et al, 2010). Due to 
their association with the SASP, it is likely that Mφs may retain key involvement in the 
senescence aspect of cutaneous wound healing.
Given the previously described link between the pro-inflammatory SASP and diabetes, we 
sought to characterise hallmark senescence biomarkers in diabetic murine skin and wounds. As 
Mφs are implicated as one of the main sources of the SASP in diabetes, we next screened 
diabetic Mφs for specific SASP components and evaluated their function. Finally, we revealed 
the translational relevance of blocking an explicated diabetic SASP receptor to promote wound 
closure.
RESULTS
Senescent cells accumulate in pathological skin and wounds. To evaluate the senescent 
phenotype in skin (D0) and wounds (D7) from normal (young) and delayed healing (Db and 
aged) mice, we first performed SA-βGAL staining (Figure 1A-B). Here, the number of SA-
βGAL+ve cells was greatest in aged dermis (P < 0.001). Interestingly, modest increases in 
dermal (P = 0.06) SA-βGAL were also visualised in the Db model. We next asked whether 
acute injury induces abnormal accumulation of senescent cells in pathological wounds. Here, 
levels of SA-βGAL+ve cells increased more than 2-fold in Db (P < 0.05) and aged (P < 0.01) 
wounds at day 7 post-injury, compared to young controls. Increased p16-specific senescence 
was also confirmed in Db wounds (Supplementary Figure S1). Further, qRT-PCR revealed 
substantially greater levels of the senescence genes, Cdkn1b (p27; P < 0.05), Cdkn2a (p16; P 
< 0.01) and Trp53 (p53; P < 0.01) in aged skin (Figure 1D, E, F, respectively). Interestingly, 
Cdkn1a was upregulated following injury in Db versus young wounds (p21; P < 0.05; Figure 
1C), and Cdkn1b (P < 0.05), Cdkn2a (P < 0.05) and Trp53 (P < 0.01) showed a trend towards 
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increase in Db wounds. By contrast, no significant changes in senescent genes were apparent 
between young and aged wounds (Figure 1). These data demonstrate for the first time that 
senescent cells rapidly accumulate following injury in Db mouse skin, and suggest a potential 
crossover between diabetes and aging wound pathology. 
The heightened macrophage response in diabetic wounds is intrinsically skewed to 
senescence and M1 polarisation. Db murine wounds are extensively used as an archetypical 
delayed healing model (reviewed in Ansell et al, 2012). Histological assessment via Masson’s 
trichrome staining confirmed delayed healing (larger wounds) in Db (Figure 2A-B) versus 
NDb controls at day 7 post-injury. Intriguingly, a large proportion of the senescent cells in Db 
wounds were Mφs, which were highly senescent compared to NDb Mφs (P < 0.001; Figure 
2C-D). Mφs are implicated in playing a major role in senescence and metainflammation 
(reviewed in Sagiv and Krizhanovsky, 2013). Thus, bone-marrow derived Mφs were isolated 
from NDb and Db mice, polarised with M1 and M2 cytokines, and characterised for a potential 
senescent phenotype via SA-βGAL staining. Here, a higher number of Db Mφs were SA-βGAL 
positive than NDb Mφs (Figure 2E-F, P < 0.001), while qRT-PCR demonstrated significantly 
increased Cdkn1a and Cdkn2a in Db M1-polarised Mφs (P < 0.05 and P < 0.01, respectively), 
and increased Cdkn1a in Db M2-polarised Mφs (P < 0.001; Figure 2G). As expected, M1-
stimulated Mφs displayed elevated Nos2, while Ym1 levels were upregulated in M2-stimulated 
Mφs (Figure 2G). However, the overall expression of both Nos2 (P < 0.001) and Ym1 (P < 
0.01) was significantly reduced in Db Mφs at 72 hours post-stimulation (Figure 2G), At the 
protein level, Db Mφs also displayed reduced polarisation (less Nos2 and Arg1 staining) and 
increased expression of the senescence marker p21 (Figure 2H).
Diabetic macrophage SASP is enriched in CXCR2 ligands that selectively induce 
chemokine and fibrotic markers in fibroblasts. Given that delayed wound healing is 
characterised by deleterious alterations in Mφ function (Bannon et al, 2013), while heightened 
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senescence is observed in Db M1 and M2 polarised Mφs, we next profiled the Db Mφ SASP 
using antibody arrays designed to detect a number of SASP-relevant soluble factors (Figure 
3A-B). For visualisation, the data were displayed as Db versus NDb fold changes. A number 
of secreted factors were upregulated in Db M2-stimulated Mφs, including the previously 
reported SASP components CXCL1, RANTES, CXCL2, MIP-1α, TNF-α, IL-1ra and TIMP-1 
(Chien et al., 2011). qRT-PCR also confirmed upregulation of the key SASP components Cxcl1 
(P < 0.05) and Cxcl2 at the mRNA level, and upregulation of their common receptor, Cxcr2 (P 
< 0.05) in Db Mφs (Figure 3C). Further, gelatin zymography revealed increased activity of the 
gelatinase, MMP-2, in Db M0 and M2-stimulated CM (P < 0.05, Figure 3D; un-enhanced gel 
Supplementary Figure S2). Moreover, returning to normal and pathological wound tissue, 
Cxcl1 (P < 0.001; Figure 3E), Cxcl2 (P < 0.05; Figure 3F) and their common receptor, Cxcr2 
(P < 0.05; Figure 3G), were all significantly elevated in Db wounds, but not in aged wounds 
(versus young).
Previously, a mesenchymal SASP has been shown to influence fibroblast differentiation during 
wound repair (Demaria et al, 2014). Given the similarities between mouse and human fibroblast 
SASP components (Coppé et al, 2010), we next determined the effect of CM from NDb and Db 
murine Mφs on HDF gene expression profile (Figure 3H). Looking at early gene expression 
changes, Db CM did not significantly alter p16 (CDKN2A), p21 (CDKN1A) or NFE2L2 (NRF2; 
oxidative stress marker; Nguyen et al., 2009) expression in young or aged HDFs, indicating no 
direct induction of fibroblast senescence markers. However, Db CM increased SERPINE1 
(PAI-1), a well-known marker of fibrosis and fibroblast senescence (Kortlever et al, 2006), in 
both aged and young HDFs, and COL1A1 (collagen type I alpha chain I) in aged HDFs. 
Curiously, COL3A1 (collagen type III alpha chain I; an early injury matrix protein) was 
downregulated in young and aged HDFs by Db CM. Together these data suggest that Db CM 
favours a pro-fibrotic fibroblast phenotype. Finally, Db CM from M1-polarised Mφs strongly 
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induced CXCL1 and CXCL2 in young and aged HDFs, while M2-polarised Db CM significantly 
induced CXCL2 in aged HDFs alone (P < 0.01).
Ectopic expression of CXCL2 potentiates CXCL2 induction and p21 nuclear localisation 
in non-transfected fibroblasts. As CXCL1/2-rich CM from Db Mφs promotes paracrine 
induction of CXCR2 ligands in HDFs, we next looked at the effect of direct transfection of 
CXCL2 in HDFs. As expected, fibroblasts transfected with a CXCL2 plasmid exhibited 
significantly higher CXCL2 expression at 2 days (P < 0.05) and 6 days (P < 0.001) post-
transfection (than controls, Figure 4A-B), suggesting clear paracrine induction of CXCL2. 
Intriguingly, by D6, CXCL2-transfected fibroblasts also exhibited higher levels of nuclear p21 
(P < 0.001; Figure 4C-D), which is associated with senescence (e.g. in endothelial cells, 
Matthaei et al., 2012), and higher SA-βGAL and p16 expression (supplementary Figure S3). 
As YFP+ve fibroblasts did not increase between D2 and D6 post-transfection (Figure 4E), 
these data suggest that CXCL2 exerts strong local paracrine effects that promote senescence 
induction. Further, transfected HDFs produced a SASP-rich secretome (Figure 4F-G) which 
displayed heightened MMP2 activity (Figure 4H-I, un-cropped gel Supplementary Figure 
S4), while intracellular expression of MMP2 and COL3A1 was increased following CXCL2 
transfection (Figure 4J).
Human wound healing is accelerated by blockade of the CXCR2 receptor. CXCL2 
secretion is increased in Db Mφs (Figure 3), CXCL2 induces senescence in HDFs (Figure 4), 
and increased senescence is linked to diabetic wound healing. We thus tested the effect of 
CXCL2 receptor (CXCR2; Acosta et al, 2008) activation/inhibition during human healing. 
Treatment of human keratinocyte (HaCaT) scratch wounds with the ligands, CXCL1 and 
CXCL2, led to a delay in closure (P < 0.05 and P < 0.01 respectively), while blockade of 
CXCR2 (SB265610; Bradley et al, 2009) significantly improved (P < 0.05) scratch wound 
repair (Supplementary Figure S5). To confirm specificity co-treatment with SB265610 and 
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either CXCL1 or CXCL2 was performed, with the effect of both chemokines completely 
blocked. Interestingly, when the two ligands (CXCL1 and CXCL2) were combined they were 
able to delay wound closure, even in the presence of SB265610 (P < 0.001).
Human ex vivo wounds were subjected to the same treatments. Here, combinatorial treatment 
with CXCL1 and CXCL2 delayed wound closure (P < 0.05; Figure 6A, C; K14 staining), while 
application of SB265610 increased healing (P < 0.01). In the presence of SB265610, CXCL1 
treatment (P < 0.05), and treatment with both ligands (P < 0.05), delayed epidermal wound 
healing. Intriguingly, combining SB265610 and CXCL2 rescued delayed wound closure 
observed with CXCL2 treatment alone, thus suggesting SB265610 to be selective for CXCL2 
ex vivo. Finally, neo-epidermal proliferation (K6 staining, Figure 6B, D) was significantly 
impaired only in wounds co-treated with SB265610 and CXCL1 (P < 0.05), further 
demonstrating SB265610 to be less effective against CXCL1 than CXCL2 (full set of 
representative images is provided in Figure S6). Together, these data clearly show that blocking 
the canonical senescence receptor, CXCR2, promotes human epidermal wound closure. 
CXCR2 antagonist treatment reduces wound size, inflammation and macrophage 
senescence during diabetic wound healing. We next returned to the diabetic mouse model, 
where we assessed the effect of blocking CXCR2 receptor on delayed-healing diabetic wound 
repair in vivo. Diabetic murine wounds were treated with SB265610 or vehicle, and collected 
at day 7 post-injury. CXCR2 antagonist-treated wounds were significantly smaller than control 
wounds (width, P < 0.01; area, P < 0.05; Figure 6A-C), with reduced local inflammation 
(neutrophil numbers; P < 0.05; Figure 6D, G). Finally, faster healing in SB265610-treated 
diabetic mouse wounds was associated with a substantial local reduction in senescent 
macrophages (P < 0.01; Figure 6F, H). Taken together these data suggest that blocking CXCR2 
promotes healing in diabetic wounds by inhibiting local macrophage senescence, reducing local 
inflammation and promoting wound re-epithelialisation.  
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DISCUSSION
Although the mechanisms are not fully understood, senescence contributes to age-related 
dysfunction, partly through regulation of the SASP (Coppé et al, 2008). Additional roles for 
SASP are emerging in embryogenesis (Storer et al, 2013) and liver regeneration (Jun and Lau, 
2010; Krizhanovsky et al, 2008; Yosef et al, 2017), while in normal wound repair, Demaria et 
al. (2014) identified PDGFA as a wound-derived SASP component driving fibroblast 
differentiation. In the present study, we focused on the role of senescence in pathological wound 
repair. For the first time, we demonstrate elevated local senescence in diabetic wound healing.   
Senescence and diabetes have previously been linked in other tissues, including pancreatic 
(Sone and Kagawa, 2005), and adipose (Minamino et al, 2009). Interestingly, young diabetic 
mice share common features with aged mice, including accumulation of advanced glycation 
end products (AGEs; Goova et al, 2001) and heightened ER stress (reviewed in Naidoo and 
Brown, 2012), which promote the onset of premature cellular senescence (Liu et al, 2014). 
Increased senescence also occurs in the kidney following streptozocin-induced diabetes 
(Satriano et al, 2010), while removal of p16+ve cells improves islet regeneration and survival 
following β cell ablation (Krishnamurthy et al, 2006). 
To delve deeper into the link between senescence and pathological repair, we focussed on 
diabetic Mφs which show delayed initial wound infiltration (Bannon et al, 2013), prolonged 
inflammation (Wood et al, 2014), and reduced M2-polarisation (Mirza et al, 2015). Our data 
revealed that Db Mφs exhibit: a) reduced polarisation-potential at 72 hours post-cytokine 
stimulation (lower Nos2 in M1- and Ym1 in M2-polarised) and; b) increased expression of 
Cdkn1a and Cdkn2a, with expression of known SASP factors (Coppé et al, 2010; Coppé et al, 
2008). It has been noted previously that a hyperglycaemic environment promotes senescence 
induction and SASP production in human Mφs (Prattichizzo et al, 2018), while glucose 
restriction extends human fibroblast lifespan in vitro (Li and Tollefsbol, 2011). Indeed, the anti-
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diabetic drug, metformin, reduces SASP in oncogene-induced senescence (Moiseeva et al, 
2013). CXCL1 and CXCL2 were identified as the most highly expressed SASP factors in 
polarised Db Mφs, in line with increased expression of Cxcr2 and its ligands in Db wound 
tissue. CXCL2 expression has been previously observed in Db wounds (Wetzler et al, 2000). 
Previous authors have demonstrated a peak in wound cellular senescence at 6-7 days post-injury 
in control mice (Demaria et al., 2014), we therefore focussed on this time-point within our study. 
A limitation of this approach is that it is unable to address temporal changes in wound 
senescence. However, our combined in vivo and in vitro findings collectively suggest that 
CXCR2 ligand upregulation is important for Db wound pathology.   
Wound healing involves extensive immune cell, fibroblast cross-talk. For example, NK cells 
promote pro-inflammatory cytokine and chemokine production in HDFs (Müller et al, 2000). 
In this study we show that the Db SASP drives a profibrotic phenotype, upregulating SERPINE1 
and COL1A1 in HDFs. In their landmark paper, Acosta et al (2008) determined CXCR2 and its 
ligands to be potent mediators of senescence in MEFs and immortalised cells, but they did not 
consider the potential paracrine effects of the SASP. Here we find that CXCL2 expression in 
HDFs potentiated over time correlating with nuclear localisation of p21. This supports a 
paracrine effect for CXCL2, or CXCL2-mediated SASP component(s) in senescence induction. 
Indeed, we find that both ectopic expression of, and exposure to CXCL2 as part of the SASP, 
mediate a senescence response in primary human dermal fibroblasts.
Fibroblast senescence is likely a contributing factor to poor healing outcome (Harding et al, 
2005) as chronic wound fibroblasts display high senescence (Ågren et al, 1999; Mendez et al, 
1998; Stephens et al, 2003; Vande Berg et al, 1998) and a correlation exists between fibroblast 
senescence and time to heal in chronic wounds (Stanley and Osler, 2001). Here we report that 
directly inhibiting the senescence mediator CXCR2 (antagonist SB265610; Bradley et al, 2009), 
significantly increased the rate of wound closure in in vitro and ex vivo human wound models. 
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Conversely, ligand treatment (CXCL1 and CXCL2) delayed HaCaT scratch wound closure. 
Intriguingly, CXCR2 inhibition rescued the effects of CXCL2 in vitro and ex vivo, yet failed to 
negate the inhibitory effects of CXCL1, or combinatorial ligand treatment. This likely reflects 
the fact that CXCL1, but not CXCL2, displays promiscuous receptor activation activity 
(reviewed in Balkwill, 2012). Curiously CXCR2 activation promotes keratinocyte migration 
and proliferation (Kroeze et al, 2012), while mice ubiquitously lacking CXCR2 display delayed 
re-epithelialisation, less wound granulation, impaired neovascularisation (Devalaraja et al, 
2000), and diminished immune cell recruitment to wounds (Milatovic et al, 2003). The present 
data further demonstrated the significance of CXCR2 antagonism in diabetic murine wound 
healing in vivo. Here, SB265610 treatment dampened neutrophil infiltration and reduced 
macrophage senescence. Thus, it appears that CXCR2 signalling must be tightly regulated for 
optimum wound repair.
Overall, these data reveal excessive CXCR2 and increased local cellular senescence in delayed 
healing diabetic wounds, while treatment with a selective CXCR2 antagonist promotes skin 
repair in human ex vivo and diabetic in vivo murine wound models. These observations provide 
the first step towards the future development of chronic wound therapies targeting the CXCR2 
receptor and, consequently, wound-induced senescence.
MATERIALS AND METHODS
Animal Experimentation. Wild-type (WT; C57Bl/6), non-diabetic (NDb; Lepr-/+) and diabetic 
(Db; Lepr-/-) mice were obtained from Envigo Ltd (UK) and housed in the Biological Services 
Facility (BSF, The University of Manchester, UK) with ad libitum access to food and water. 
NDb, Db and “young” WT mice were wounded at 8-10 weeks old, while “aged” WT mice were 
wounded at 80-90 weeks of age. Cages were kept under constant temperature, humidity and a 
12-hour light-dark cycle. All animal procedures were carried out according to Home Office 
regulations. 
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Wounding Experiments. Mice were anaesthetised and wounded using our established protocol 
(Ashcroft et al, 2003). Briefly, two equidistant full-thickness 1cm incisional wounds were made 
on the dorsum of young and aged mice, while two full thickness 6 mm dorsal excisional wounds 
were created on NDb and Db mice. Mice were administered buprenorphine post-operatively 
and monitored regularly prior to wound collection at 7 days post-injury (see Supplementary 
Materials and Methods). For drug treatments, the CXCR2 antagonist, SB265610 (R&D systems, 
Abingdon, UK), was administered subcutaneously to wounds at 1 mg/kg of animal body weight. 
Control mice were treated with a vehicle only (1% DMSO in Dulbecco’s phosphate buffered 
saline). Treatments were given at time of wounding, and at day 2 (D2), D4 and D6 post-injury. 
Histological Analysis. SA-βGAL (senescence associated β-D-galactosidase) staining and p16 
immunohistochemistry was performed to measure senescent cell accumulation in normal skin 
(D0) and wound tissue (D7). Wound healing analysis was determined with Masson’s Trichrome 
staining and senescent Mφs were stained via immunofluorescence (Supplementary Materials 
and Methods). 
Quantitative real-time PCR (qRT-PCR). RNA was extracted from wounds, normal skin tissue 
and cells. Primer sequences are provided in the Supplementary Materials and Methods.
Macrophage Activation. Mononuclear phagocyte progenitor cells were isolated from murine 
bone marrow as described (Supplementary Materials and Methods). On day 7 post-isolation, 
Mφs were stimulated with LPS (100 ng/ml; Sigma-Aldrich, Suffolk, UK) and IFN-γ (100 ng/ml; 
Sigma-Aldrich) to become M1-like, with IL-4 (20 ng/ml; Sigma-Aldrich) and anti-IFN-γ (50 
µg/ml; 2BScientific, Upper Heyford, UK) to become M2-like and with DMEM and no 
supplements to remain non-stimulated (M0). Mφs were incubated overnight at 37 ºC with 5 % 
CO2 and collected for RNA isolation, immunocytochemistry (Supplementary Materials and 
Methods), or used for subsequent fibroblast SASP conditioning experiments.
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SASP Conditioning. Activation media was aspirated, replaced with fresh Mφ media (w/o L929 
CM), and Mφs were incubated at 37 ºC and 5 % CO2 for 48 hours. Mφ CM and RNA was 
collected and stored at -80 ºC until use. Primary human dermal fibroblasts (HDFs) were isolated 
from skin (see Supplementary Materials and Methods) obtained under LREC approval 
(17/SC/0220) and full informed patient consent. HDFs were isolated from 3 young (< 50 years 
of age) and 3 aged (> 75 years of age) donors (Supplementary Materials and Methods), treated 
with Mφ CM for 24 hours at 37 ºC and 5 % CO2, and collected for RNA. 
SASP Characterisation. CM from NDb and Db M1-stimulated and M2-stimulated Mφs was 
characterised using the Proteome Profiler Mouse Cytokine Array Kit (R&D systems) following 
manufacturer’s instructions. Developed films were imaged and integrated density analysis 
performed in ImageJ v.1.8 (NIH, US). As the proteome array could not identify the expression 
of matrix metalloproteinases (MMPs), gelatin zymography was utilised for this purpose (as in 
Wilkinson et al, 2018). 
Transfection. HDFs were transfected with a control plasmid (pUNO1-mcs), or CXCL2-
containing plasmid (pUNO1-CXCL2; both InvivoGen, Toulouse, France) using 
Lipofectamine™ 3000 reagent (Thermo Fisher Scientific) according to manufacturer’s 
guidelines. Transfection efficiency was monitored using a YFP-containing plasmid (pCW109, 
a kind gift from Dr Cheryl Walter). Transfected fibroblasts were collected two days and six 
days post-transfection. Immunocytochemistry, qRT-PCR and zymography was performed as 
described in the Supplementary Materials and Methods. HDF CM was profiled with a Proteome 
Profiler Human Cytokine Array Kit (R&D systems) following manufacturer’s instructions.
Human Wound Repair. To assess the effects of CXCR2 blockade on human wound repair, 
analyses were performed on confluent monolayers of HaCaTs in vitro, and human wounds ex 
vivo as described in the Supplementary Materials and Methods. 
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Statistical Analysis. Data were shown as mean +/- standard deviations of the mean (SEM). 
Statistical tests (independent t tests, one-way ANOVA and two-way ANOVA) were performed 
on all quantitative data using GraphPad Prism 7 (GraphPad Software, California, US). Where 
applicable, post-hoc tests (Sidak, Dunnett’s and Tukey) were performed. Differences between 
experimental groups were deemed significant when P < 0.05. 
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6
FIGURE LEGENDS
Figure 1. SA-βGAL staining elucidates pathological accumulation of senescent cells in 
murine skin and wounds. Here, senescence-associated beta galactosidase (SA-βGAL) 
staining illustrated increased senescent dermal cells in aged skin and diabetic (Db) and aged 
wounds (a, compared to young). Representative images of SA-βGAL+ve (blue) cells are shown 
in b, depicted by black arrows (n=5-6 per group). Bars = 100 µm. Further profiling of 
senescence markers via qRT-PCR demonstrated an increase in Cdkn1a (c), Cdkn1b (d), Cdkn2a 
(e) and Trp53 (f) in aged skin, while Cdkn1a was only upregulated in Db wounds. D0 = normal 
skin. D7 = day 7 post-injury wounds. n=3-4 per group. Data represent mean +/- SEM. * = P < 
0.05, ** = P < 0.01, *** = P < 0.001.
Figure 2. Diabetic wounds show heightened recruitment of macrophages, which are 
intrinsically susceptible to senescence. Masson’s Trichrome staining comparing diabetic (Db) 
and non-diabetic (NDb) wounds (a; quantified in b) at day 7 post-injury. Wound edges = black 
arrows. Bar = 500 µm. Db wounds contain highly senescent macrophages (Mφs; c), 
demonstrated via representative immunofluorescence (d, white arrows). Bar = 20 µm. n=4-6 
mice per group. Bone marrow-derived Db Mφs demonstrated significantly more SA-βGAL+ve 
staining (e; blue cells, f). Bar = 50 µm. Polarised Db Mφs possessed heightened Cdkn1a and 
Cdkn2a mRNA 72 hours post-cytokine stimulation with less Nos2 and Ym1 than NDb Mφs (g). 
Immunofluorescence further demonstrates reduced polarisation of Db Mφs (merged images, 
h). Bar = 20 µm. n=5 animals per group. Data show mean +/- SEM. * = P < 0.05, ** = P < 
0.01, *** = P < 0.001. 
Figure 3. Diabetic macrophages produce a SASP governed by the CXCR2 receptor that 
alters human dermal fibroblast gene expression. Cytokine array of conditioned media (CM) 
from M1 and M2 non-diabetic (NDb) and diabetic (Db) macrophages (Mφs; a-b; two 
independent experiments; representative M2 blots). CXCL1 = not expressed in NDb M2 Mφs 
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(∞). qRT-PCR of Cxcl1, Cxcl2 and Cxcr2 in Db Mφs (c). Zymography of Mφ CM protease 
(quantified in d). qRT-PCR for Cxcl1 (e), Cxcl2 (f) and Cxcr2 (g), performed on skin (D0) and 
wounds (D7) from mice. Mφ CM stimulated changes in human dermal fibroblast gene 
expression (Db versus NDb fold changes, h). n=3 human donors per group. Fold changes above 
4 and below -4 = saturated colour. Data show mean +/- SEM. * = P < 0.05, ** = P < 0.01, *** 
= P < 0.001. 
Figure 4. Ectopic expression of CXCL2 induces paracrine activity that influences nuclear 
localisation of p21. Human dermal fibroblasts transfected with a CXCL2-containing plasmid 
show heightened levels of CXCL2 (green fluorescence) at day 2 (D2) post-transfection, that are 
further upregulated by D6 (a, quantified in b). CXCL2-transfected fibroblasts also displayed 
elevated nuclear p21 (red fluorescence) by D6 post-transfection (c-d). DAPI = nuclei. CTCF = 
corrected total cell fluorescence. Bar = 50 µm. YFP-positive staining (e). CXCL2 expressing 
HDFs also produced a SASP-rich secretome (blot, f, graph, g), while zymography shows 
changes in MMP2 activity (h, representative of 3 gels, quantification in i). qRT-PCR 
demonstrated changes in MMP2, COL3A1 and C L1A1 between control-transfected and 
CXCL2-transfected HDFs (j). Data = mean +/- SEM. * = P < 0.05, *** = P < 0.001. 
Figure 5. Early phase wound repair is accelerated by blockade of CXCR2 in human ex 
vivo healing. K14 staining (a and c) demonstrated a significant increase in epidermal wound 
closure after 3 days following treatment of human ex vivo wounds with the CXCR2 antagonist, 
SB265610 (E; arrows show wound edges, bar = 200 µm), whereas combined treatment with 
CXCL1 and CXCL2 delayed healing (D). Combining SB265610 with CXCL2 (G), but not 
CXCL1 (F), rescued the delay in wound healing, but SB265610 did not rescue healing with 
combinatory ligand treatment (H). Letters in a and b relate to treatments in c and d. K6 staining 
(b; bar = 50 µm), depicted increased neo-epidermal proliferation following SB265610 
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treatment (d). Dotted lines = neo-epidermis. n=3 donors per treatment. Data show mean +/- 
SEM. * = P < 0.05, ** = P < 0.01. 
Figure 6. Blocking CXCR2 significantly improves diabetic wound healing in vivo. 
Haematoxylin and eosin (a) staining showed significantly reduced wound width (b) and area 
(c) following SB265610 treatment (arrows show wound edges, bar = 500 µm). Immune cell 
infiltration was dampened, quantified from neutrophil (d) and macrophage (e) staining. 
Macrophage (Mac3) senescence (p16+ve macrophages) was also reduced following SB265610 
treatment (f). DAPI = nuclei; Alexa Fluor® 488 = Mac3; Alexa Fluor® 647 = p16. 
Representative images (g and h). Bar = 50 µm. Wounds collected at day 7 post-injury. Arrows 
show positively stained cells. Data show mean +/- SEM. * = P < 0.05, ** = P < 0.01, *** = P 
< 0.001.
SUPPLEMENTARY MATERIAL
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Figure 1. SA-βGAL staining elucidates pathological accumulation of senescent cells in murine skin 
and wounds. Here, senescence-associated beta galactosidase (SA-βGAL) staining illustrated increased 
senescent dermal cells in aged skin and diabetic (Db) and aged wounds (a, compared to young). 
Representative images of SA-βGAL+ve (blue) cells are shown in b, depicted by black arrows (n=5-6 per 
group). Bars = 100 µm. Further profiling of senescence markers via qRT-PCR demonstrated an increase in 
Cdkn1a (c), Cdkn1b (d), Cdkn2a (e) and Trp53 (f) in aged skin, while Cdkn1a was only upregulated in Db 
wounds. D0 = normal skin. D7 = day 7 post-injury wounds. n=3-4 per group. Data represent mean +/- 
SEM. * = P < 0.05, ** = P < 0.01, *** = P < 0.001. 
83x114mm (300 x 300 DPI) 
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Figure 2. Diabetic wounds show heightened recruitment of macrophages, which are intrinsically 
susceptible to senescence. Masson’s Trichrome staining comparing diabetic (Db) and non-diabetic (NDb) 
wounds (a; quantified in b) at day 7 post-injury. Wound edges = black arrows. Bar = 500 µm. Db wounds 
contain highly senescent macrophages (Mφs; c), demonstrated via representative immunofluorescence (d, 
white arrows). Bar = 20 µm. n=4-6 mice per group. Bone marrow-derived Db Mφs demonstrated 
significantly more SA-βGAL+ve staining (e; blue cells, f). Bar = 50 µm. Polarised Db Mφs possessed 
heightened Cdkn1a and Cdkn2a mRNA 72 hours post-cytokine stimulation with less Nos2 and Ym1 than NDb 
Mφs (g). Immunofluorescence further demonstrates reduced polarisation of Db Mφs (merged images, h). 
Bar = 20 µm. n=5 animals per group. Data show mean +/- SEM. * = P < 0.05, ** = P < 0.01, *** = P < 
0.001. 
87x114mm (300 x 300 DPI) 
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Figure 3. Diabetic macrophages produce a SASP governed by the CXCR2 receptor that alters 
human dermal fibroblast gene expression. Cytokine array of conditioned media (CM) from M1 and M2 
non-diabetic (NDb) and diabetic (Db) macrophages (Mφs; a-b; two independent experiments; 
representative M2 blots). CXCL1 = not expressed in NDb M2 Mφs (∞). qRT-PCR of Cxcl1, Cxcl2 and Cxcr2 in 
Db Mφs (c). Zymography of Mφ CM protease (quantified in d). qRT-PCR for Cxcl1 (e), Cxcl2 (f) and Cxcr2 
(g), performed on skin (D0) and wounds (D7) from mice. Mφ CM stimulated changes in human dermal 
fibroblast gene expression (Db versus NDb fold changes, h). n=3 human donors per group. Fold changes 
above 4 and below -4 = saturated colour. Data show mean +/- SEM. * = P < 0.05, ** = P < 0.01, *** = P 
< 0.001. 
74x99mm (600 x 600 DPI) 
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Figure 4. Ectopic expression of CXCL2 induces paracrine activity that influences nuclear 
localisation of p21. Human dermal fibroblasts transfected with a CXCL2-containing plasmid show 
heightened levels of CXCL2 (green fluorescence) at day 2 (D2) post-transfection, that are further 
upregulated by D6 (a, quantified in b). CXCL2-transfected fibroblasts also displayed elevated nuclear p21 
(red fluorescence) by D6 post-transfection (c-d). DAPI = nuclei. CTCF = corrected total cell fluorescence. 
Bar = 50 µm. YFP-positive staining (e). CXCL2 expressing HDFs also produced a SASP-rich secretome (blot, 
f, graph, g), while zymography shows changes in MMP2 activity (h, representative of 3 gels, quantification 
in i). qRT-PCR demonstrated changes in MMP2, COL3A1 and COL1A1 between control-transfected and 
CXCL2-transfected HDFs (j). Data = mean +/- SEM. * = P < 0.05, *** = P < 0.001. 
74x94mm (600 x 600 DPI) 
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Figure 5. Early phase wound repair is accelerated by blockade of CXCR2 in human ex vivo 
healing. K14 staining (a and c) demonstrated a significant increase in epidermal wound closure after 3 days 
following treatment of human ex vivo wounds with the CXCR2 antagonist, SB265610 (E; arrows show 
wound edges, bar = 200 µm), whereas combined treatment with CXCL1 and CXCL2 delayed healing (D). 
Combining SB265610 with CXCL2 (G), but not CXCL1 (F), rescued the delay in wound healing, but 
SB265610 did not rescue healing with combinatory ligand treatment (H). Letters in a and b relate to 
treatments in c and d. K6 staining (b; bar = 50 µm), depicted increased neo-epidermal proliferation 
following SB265610 treatment (d). Dotted lines = neo-epidermis. n=3 donors per treatment. Data show 
mean +/- SEM. * = P < 0.05, ** = P < 0.01. 
74x114mm (300 x 300 DPI) 
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Figure 6. Blocking CXCR2 significantly improves diabetic wound healing in vivo. Haematoxylin and 
eosin (a) staining showed significantly reduced wound width (b) and area (c) following SB265610 treatment 
(arrows show wound edges, bar = 500 µm). Immune cell infiltration was dampened, quantified from 
neutrophil (d) and macrophage (e) staining. Macrophage (Mac3) senescence (p16+ve macrophages) was 
also reduced following SB265610 treatment (f). DAPI = nuclei; Alexa Fluor® 488 = Mac3; Alexa Fluor® 647 
= p16. Representative images (g and h). Bar = 50 µm. Wounds collected at day 7 post-injury. Arrows show 
positively stained cells. Data show mean +/- SEM. * = P < 0.05, ** = P < 0.01, *** = P < 0.001. 
74x96mm (300 x 300 DPI) 
Page 30 of 43Journal of Investigative Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 ©2019, Elsevier. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
For Review Only
SUPPLEMENTARY TEXT
Supplementary Materials and Methods:
Tissue collection. Skin and wound tissue was collected from mice 7 days post-injury. Wounds 
were bisected at their midpoint and: a) placed in neutral buffered formalin for wax histology; 
b) flash frozen in liquid nitrogen and stored at -80 ºC for RNA analysis; and c) embedded in 
optimum cutting temperature medium (OCT) for SA-βGAL staining.
Histological analysis. Masson’s trichrome staining and haematoxylin and eosin staining was 
performed on wax-embedded tissue sections (5 µm thick). Immunohistochemistry used rat anti- 
Ly-6G/Ly-6C (Clone NIMP-R14; Thermo Fisher Scientific, Paisley, UK), rat anti-Mac-3 
(Clone M3/84; BD Biosciences, Reading, UK), goat anti-vimentin (VIM; Sigma-Aldrich, 
Dorset, UK), rabbit anti-p16 (Clone H-43; Santa Cruz Biotechnology, Heidelberg, Germany), 
rabbit anti-keratin 6A (Clone Poly19057) and rabbit anti-keratin 14 (Clone Poly19053; both 
Covance, London, UK) primary antibodies. For brightfield microscopy, appropriate 
biotinylated secondary antibody and VECTASTAIN® elite ABC kit were used with 
NovaRED™ peroxidase substrate (Vector Laboratories, Peterborough, UK). Tissue was 
counterstained with Gill’s haematoxylin (Thermo Fisher Scientific, Paisley, UK). All 
brightfield images were taken with a Nikon E400 microscope and SPOT camera (Image 
Solutions, Inc. Michigan, US). Wound measurements were analysed in ImagePro-Plus v.6.3.0 
(Media cybernetics, Cambridge, UK). For immunofluorescence, appropriate Alexa Fluor®-
conjugated secondary antibodies were used (Alexa Fluor® 488 – Mac3; Alexa Fluor® 594 and 
647 – p16; Thermo Fisher Scientific) and slides mounted with MOWIOL 488 (Sigma-Aldrich) 
containing DAPI (Thermo Fisher Scientific). Images were taken on a confocal laser scanning 
microscope (LSM 710, Zeiss) equipped with a 20x objective lens (Carl Zeiss Ltd., Cambridge, 
UK). DAPI, Alexa Fluor® 488, Alexa Fluor® 594 and Alexa Fluor® 647 were excited using 
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the 405 nm diode, 488 nm argon, 561 nm and 633 nm DPSS lasers, respectively. Pinhole size 
was equalled between lasers for optimum confocality. Mac3+ve and p16+ve cells were counted 
using ImageJ v.1.8.0.
qRT-PCR. RNA was extracted via homogenisation (tissue) or vortexing (cells) in Ambion™ 
TRIzol® reagent (Thermo Fisher Scientific). The aqueous phase was purified with the 
Ambion™ PureLink™ Mini Kit (Thermo Fisher Scientific). RNA purity and concentration was 
assessed with a Nanodrop spectrophotometer and adjusted to 1 µg/10 µl RNAse free water for 
cDNA synthesis. RNA was reverse transcribed with Bioscript™ (Bioline, London, UK) and 
random primers (Promega, Southampton, UK). The cDNA was diluted over three orders of 
magnitude and amplified with 2X Takyon SYBR Mastermix (Eurogentec, Hampshire, UK) and 
optimised primer sets on a CFX Connect™ qRT-PCR machine (Bio-Rad Laboratories, 
Hertfordshire, UK). Expression ratios of each gene were normalised to two housekeeping genes. 
Primer sequences are provided in Supporting Information Table 1.
Macrophage culture. Mononuclear phagocyte progenitor cells (from murine bone marrow) 
were cultured in low (NDb; LG; 1000 mg/L) or high (Db; HG; 4500 mg/L) glucose Dulbecco’s 
Modified Essential Medium (DMEM, Sigma-Aldrich) with 10 % heat-inactivated foetal bovine 
serum (FBS, Thermo Fisher Scientific), 100 U/ml penicillin and 100 µg/ml streptomycin (P/S 
solution; Thermo Fisher Scientific). Differentiation (via M-CSF and other cytokines) of the 
progenitor cells into Mφs was propagated with L929 cell (NCTC clone 929, ATCC® CCL-
1™) conditioned media (CM; as in Weischenfeldt et al., 2008). 
Macrophage immunocytochemistry. Macrophages (Mφs), seeded on coverslips, were fixed 
with ice-cold methanol and probed for immunocytochemistry using the following antibodies: 
mouse anti-Nos2 (clone C-11), mouse anti-Arg1 (clone E-2), rabbit anti-p16 (above) and rat 
anti-p21 (clone HUGO291; Abcam, Cambridge, UK). Appropriate Alexa Fluor®-conjugated 
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secondary antibodies were used (Alexa Fluor® 488 – p16 and p21; Alexa Fluor® 594 – Nos2 
and Arg1; Thermo Fisher Scientific) and coverslips mounted with MOWIOL 488 (Sigma-
Aldrich) containing DAPI (Thermo Fisher Scientific). Images were taken on a confocal laser 
scanning microscope as described above.
Human fibroblast isolation. Human skin was collected under full ethical approval and 
informed consent from patients undergoing routine surgeries at Castle Hill Hospital, 
Cottingham, Hull (LREC 17/SC/0220). The subcutaneous adipose tissue was removed, and the 
skin was incubated in 0.2 % Dispase I (Thermo Fisher Scientific) O/N at 4 ºC. The following 
day, the epidermis and dermis were separated and human dermal fibroblasts (HDFs) isolated 
from the dermis using the Whole Skin Dissociation Kit skin and gentleMACS™ Dissociator 
(both Miltenyi Biotec Ltd, Woking, UK) following manufacturer’s instructions. HDFs were 
cultured in standard Gibco HG DMEM containing 10 % FBS and 1 % P/S solution (Thermo 
Fisher Scientific).
Transfection experiments. Following transfection, immunocytochemistry of HDFs was 
performed with mouse anti-p21 (clone F5), rabbit anti-p16 (above; both Santa Cruz 
Biotechnology) and goat anti-CXCL2 (ab91511; Abcam) antibodies. Antibody-antigen binding 
was detected with Alexa Fluor® 488 and 594-conjugated secondary antibodies (Thermo Fisher 
Scientific) and the cytoskeleton was counterstained with Rhodamine-conjugated phallodin 
(Thermo Fisher Scientific) where shown. Coverslips were mounted with MOWIOL 488 
(Sigma-Aldrich) containing DAPI (Thermo Fisher Scientific) and images captured via confocal 
laser scanning microscope (described above). Corrected total cell fluorescence (CTCF) was 
determined using ImageJ v.1.8 (NIH; as in McCloy et al., 2014), to compare CXCL2, p21 and 
p16 expression in MCS (pUNO1) and CXCL2 (pUNO1) transfected groups. YFP+ve cells were 
also counted using ImageJ v.1.8.0. 
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Scratch analysis. Confluent monolayers of HaCaTs (purchased from AddexBio, San Diego, 
US) were scratched with a sterile 1ml filter tip and treated with a vehicle (BSA/DMSO) or the 
CXCR2 ligands, CXCL1 and CXCL2 (30 ng/ml; R&D systems) alone and in combination. 
HaCaTs were also treated with a CXCR2 antagonist (100 nM, SB265610; R&D systems) alone 
or in combination with the ligands for 24 hours. Scratches, stained with 1 % crystal violet, were 
imaged (Nikon E400 microscope) and analysed in ImageJ V.1.8.0 (NIH).
Human ex vivo wounding. Human skin was washed in 2X antibiotic-antimycotic solution 
(Thermo Fisher Scientific) and defatted prior to wounding. Partial thickness (2 mm) wounds 
were created within 6 mm biopsies (using Stiefel biopsy punches, Stiefel Laboratories, NC, US). 
Wounds were placed on top of a sterile 0.22 µm membrane at the air-membrane interface on 
two absorbent pads (both Merck, Hertfordshire, UK) in 5mm petri dishes. HG DMEM, 
containing 10% FBS and 1% antibiotic-antimycotic solution, was added to the bottom of the 
dish. Treatments (described for scratch assays) were applied topically and re-administered daily. 
After 72 hours, samples were fixed (above) and epidermal repair was assessed via K6 and K14 
histology (see above).
Supplementary Figure Legends:
Supplementary Figure S1. Aged skin and wounds possess high levels of p16. 
Immunohistochemistry or p16 staining in normal skin (D0) and wounds at day 7 post-injury 
(D7; a) from young, diabetic (Db) and aged mice. Representative images (b) show p16+ve cells 
(brown, black arrow). Bar = 50 µm. Data show mean +/- SEM. * = P < 0.05, ** = P < 0.01.
Supplementary Figure S2. Original zymography gel from Figure 3. Lane 1: Molecular 
weight ladder; Lane 3: Non-diabetic (NDb) M0 CM (conditioned media); Lane 4: NDb M1 
CM; Lane 5: NDb M2 CM; Lane 6: Diabetic (Db) M0 CM; Lane 7: Db M1 CM; and Lane 8: 
Db M2 CM.
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Supplementary Figure S3. Ectopic expression of CXCL2 drives upregulation of senescent 
markers in human fibroblasts. CXCL2-transfected fibroblasts show increased p16 (red; 
nuclei, blue) at D6 (day 6) post-transfection (a-b). Bar = 50 µm. CTCF = corrected total cell 
fluorescence. SA-βGAL staining is also increased in CXCL2-transfected fibroblasts at D2 and 
D6 (c-d). Bar = 100 µm. Data show mean +/- SEM. *** = P < 0.001.
Supplementary Figure S4. Original zymography gel from Figure 4. Lane 1: Molecular 
weight ladder; Lane 2: MMP2 standard. Lane 4: Control Day 2 CM (conditioned media); Lane 
5: Control Day 6 CM; Lane 6: CXCL2 Day 2 CM; Lane 7: CXCL2 Day 6 CM.
Supplementary Figure S5. CXCR2 inhibition promotes HaCaT scratch migration after 24 
hours treatment. The CXCR2 ligands, CXCL1 (A) and CXCL2 (B), impaired in vitro HaCaT 
wound closure (b), while treatment with the CXCR2 antagonist, SB265610 (E), accelerated 
scratch closure (representative of 3 independent experiments). Further, treatment with CXCL1 
(F) and CXCL2 (G) with SB265610 independently did not delay scratch closure, whereas 
SB265610 failed to improve HaCaT migration when both ligands were combined (H). Crystal 
Violet-stained scratches are presented in a. Letters in a relate to treatments in b. Bar = 250 µm. 
* = P < 0.05, ** = P < 0.01, *** = P < 0.001. 
Supplementary Figure S6. Complete representative images for human ex vivo wounding 
experiments. Keratin 14 (K14) and keratin 6 (K6) images of ex vivo wounds treated with a 
vehicle (A), CXCR2 ligands (CXCL1 and CXCL2) or the CXCR2 antagonist, SB265610 (alone, 
E). Wounds were also treated with combinations of the CXCR2 ligands and SB265610. The 
panel below the images explains the treatment groups labelled A-H. Arrows depict wound edges 
(K14). Dotted lines depict neo-epidermis (K6). K14 Bars = 200 µm. K6 Bars = 50 µm. Images 
representative of 3 human donors.
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Supplementary Table S1. Primer sequences used for RT-qPCR*#
Primer Forward Sequence Reverse Sequence
mGapdh TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG
m18s AGTCCCTGCCTTTGTACACA CATCCGAGGGCCTAACTAAC
mYm1 GGCTACACTGGAGAAAATAGTCCCC CCAACCCACTCATTACCCTGATAG
mNos2 GTGGTGACAAGCACATTTGG AAGGCCAAACACAGCATACC
mCdkn1a 
(p21)#
CAGTACTTCCTCTGCCCTGC GCTCAGACACCAGAGTGCAA
mCdkn1b 
(p27)
TTGGGTCTCAGGCAAACTCT TTCTGTTCTGTTGGCCCTTT
mCdkn2a 
(p16)
GTACCCCGATTCAGGTGATG CAGTTCGAATCTGCACCGTA
mTrp53 (p53) AGAGACCGCCGTACAGAAGA CTGTAGCATGGGCATCCTTT
mCxcl1 GCTGGGATTCACCTCAAGAA TGGGGACACCTTTTAGCATC
mCxcl2 AGTGAACTGCGCTGTCAATG TTCAGGGTCAAGGCAAACTT
mCxcr2 ATCTTCGCTGTCGTCCTTGT AGCCAAGAATCTCCGTAGCA
hGAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG
hYWHAZ ACTTTTGGTACATTGTGGCTTCAA CCGCCAGGACAAACCAGTAT
hSERPINE1 
(PAI-1)
ATACTGAGTTCACCACGCCC GTTGGTGAGGGCAGAGAGAG
hCDKN1A GACTCTCAGGGTCGAAAACG CTCTTGGAGAAGATCAGCCG
hCDKN2A GAGCAGCATGGAGCCTTC CCGTAACTATTCGGTGCGTT
hCXCL2 GCAGGGAATTCACCTCAAGA GGATTTGCCATTTTTCAGCA
hCXCL1 ATTCACCCCAAGAACATCCA TGGATTTGTCACTGTTCAGCA
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hCOL1A1 CACACGTCTCGGTCATGGTA CGGCTCCTGCTCCTCTTAG
hCOL3A1 ATATTTGGCATGGTTCTGGC TGGCTACTTCTCGCTCTGCT
hFN1 TGACCCCTACACAGTTTCCCA TGATTCAGACATTCGTTCCCAC
hNFE2L2 
(NRF2)
AAACCAGTGGATCTGCCAAC ACGTAGCCGAAGAAACCTCA
hPDGFA ACACGAGCAGTGTCAAGTGC CCTGACGTATTCCACCTTGG
hMMP2 ATGACAGCTGCACCACTGAG ATTTGTTGCCCAGGAAAGTG
*Housekeeping genes: mGapdh and m18s (mouse) and hGAPDH and hYWHAZ (human). 
#Encoded protein is provided in brackets if this differed from gene nomenclature.
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Supplementary Figure S1. Aged skin and wounds possess high levels of p16. Immunohistochemistry 
or p16 staining in normal skin (D0) and wounds at day 7 post-injury (D7; a) from young, diabetic (Db) and 
aged mice. Representative images (b) show p16+ve cells (brown, black arrow). Bar = 50 µm. Data show 
mean +/- SEM. * = P < 0.05, ** = P < 0.01. 
127x130mm (300 x 300 DPI) 
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Supplementary Figure S2. Original zymography gel from Figure 3. Lane 1: Molecular weight ladder; 
Lane 3: Non-diabetic (NDb) M0 CM (conditioned media); Lane 4: NDb M1 CM; Lane 5: NDb M2 CM; Lane 6: 
Diabetic (Db) M0 CM; Lane 7: Db M1 CM; and Lane 8: Db M2 CM. 
98x69mm (300 x 300 DPI) 
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Supplementary Figure S3. Ectopic expression of CXCL2 drives upregulation of senescent markers 
in human fibroblasts. CXCL2-transfected fibroblasts show increased p16 (red; nuclei, blue) at D6 (day 6) 
post-transfection (a-b). Bar = 50 µm. CTCF = corrected total cell fluorescence. SA-βGAL staining is also 
increased in CXCL2-transfected fibroblasts at D2 and D6 (c-d). Bar = 100 µm. Data show mean +/- SEM. 
*** = P < 0.001. 
144x110mm (300 x 300 DPI) 
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Supplementary Figure S4. Original zymography gel from Figure 4. Lane 1: Molecular weight ladder; 
Lane 2: MMP2 standard. Lane 4: Control Day 2 CM (conditioned media); Lane 5: Control Day 6 CM; Lane 6: 
CXCL2 Day 2 CM; Lane 7: CXCL2 Day 6 CM. 
95x62mm (300 x 300 DPI) 
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Supplementary Figure S5. CXCR2 inhibition promotes HaCaT scratch migration after 24 hours 
treatment. The CXCR2 ligands, CXCL1 (A) and CXCL2 (B), impaired in vitro HaCaT wound closure (b), 
while treatment with the CXCR2 antagonist, SB265610 (E), accelerated scratch closure (representative of 3 
independent experiments). Further, treatment with CXCL1 (F) and CXCL2 (G) with SB265610 independently 
did not delay scratch closure, whereas SB265610 failed to improve HaCaT migration when both ligands were 
combined (H). Crystal Violet-stained scratches are presented in a. Letters in a relate to treatments in b. Bar 
= 250 µm. * = P < 0.05, ** = P < 0.01, *** = P < 0.001. 
117x112mm (300 x 300 DPI) 
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Supplementary Figure S6. Complete representative images for human ex vivo wounding 
experiments. Keratin 14 (K14) and keratin 6 (K6) images of ex vivo wounds treated with a vehicle (A), 
CXCR2 ligands (CXCL1 and CXCL2) or the CXCR2 antagonist, SB265610 (alone, E). Wounds were also 
treated with combinations of the CXCR2 ligands and SB265610. The panel below the images explains the 
treatment groups labelled A-H. Arrows depict wound edges (K14). Dotted lines depict neo-epidermis (K6). 
K14 Bars = 200 µm. K6 Bars = 50 µm. Images representative of 3 human donors. 
113x150mm (300 x 300 DPI) 
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